BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11306895)

  • 1. Does acute urinary retention respond to alpha-blockers alone?
    McNeill SA
    Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis.
    Annemans L; Cleemput I; Lamotte M; McNeill A; Hargreave T
    BJU Int; 2005 Sep; 96(4):566-71. PubMed ID: 16104911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-adrenergic blockers as a support in the treatment of acute urinary retention].
    Altarac S
    Lijec Vjesn; 2006; 128(7-8):233-7. PubMed ID: 17087140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.
    Zeif HJ; Subramonian K
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006744. PubMed ID: 19821385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.
    McNeill SA; Hargreave TB;
    J Urol; 2004 Jun; 171(6 Pt 1):2316-20. PubMed ID: 15126812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
    Shah T; Palit V; Biyani S; Elmasry Y; Puri R; Flannigan GM
    Eur Urol; 2002 Oct; 42(4):329-32; discussion 332. PubMed ID: 12361896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
    Lo KL; Chan MC; Wong A; Hou SM; Ng CF
    Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.
    McNeill SA; Daruwala PD; Mitchell ID; Shearer MG; Hargreave TB
    BJU Int; 1999 Oct; 84(6):622-7. PubMed ID: 10510105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention*.
    Palit V; Shah T; Biyani CS; Elmasry Y; Sarkar R; Flannigan GM; Puri R
    Int Urol Nephrol; 2005; 37(3):507-10. PubMed ID: 16307331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do alpha-blockers prevent the occurrence of acute urinary retention?
    Hartung R
    Eur Urol; 2001 Mar; 39 Suppl 6():13-8. PubMed ID: 11306896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective pilot study to validate the management protocol for patients presenting with acute urinary retention: a community-based, nonhospitalised protocol.
    Gopi SS; Goodman CM; Robertson A; Byrne DJ
    ScientificWorldJournal; 2006 Jun; 6():2436-41. PubMed ID: 17619714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis on management of acute urinary retention.
    Yoon PD; Chalasani V; Woo HH
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.